$0.38 EPS Expected for Natus Medical Inc (BABY)

September 17, 2017 - By Louis Casey

 $0.38 EPS Expected for Natus Medical Inc (BABY)
Investors sentiment increased to 1.93 in Q4 2016. Its up 0.82, from 1.11 in 2016Q3. It improved, as 11 investors sold Natus Medical Inc shares while 56 reduced holdings. 51 funds opened positions while 78 raised stakes. 29.10 million shares or 6.34% more from 27.36 million shares in 2016Q3 were reported.
Schwab Charles Invest Mgmt holds 179,990 shares. Assetmark stated it has 0% in Natus Medical Inc (NASDAQ:BABY). 5,789 are owned by Hanson Mcclain Inc. Johnson Investment Counsel stated it has 0.01% in Natus Medical Inc (NASDAQ:BABY). Everpoint Asset Mngmt Lc reported 50,000 shares. 91,495 are owned by Penn Mgmt Co. 36 are owned by Finemark Bankshares Tru. Renaissance Technology Ltd Liability holds 0% or 45,800 shares. Blackrock Ltd Liability Corporation owns 17,375 shares. 5,919 were reported by 1St Glob Advsrs. Swiss Natl Bank reported 0% of its portfolio in Natus Medical Inc (NASDAQ:BABY). Kennedy Mngmt has invested 0.17% in Natus Medical Inc (NASDAQ:BABY). Millennium Mgmt Limited Com reported 0.05% of its portfolio in Natus Medical Inc (NASDAQ:BABY). Stifel Fincl holds 0.03% or 209,766 shares. Callahan Advsrs Llc invested 0.29% in Natus Medical Inc (NASDAQ:BABY).

Since May 25, 2017, it had 2 buys, and 1 insider sale for $175,360 activity. 5,000 shares valued at $163,400 were sold by Engibous Doris on Thursday, May 25.

Analysts await Natus Medical Inc (NASDAQ:BABY) to report earnings on October, 18. They expect $0.38 EPS, down 2.56 % or $0.01 from last year’s $0.39 per share. BABY’s profit will be $12.56 million for 23.09 P/E if the $0.38 EPS becomes a reality. After $0.34 actual EPS reported by Natus Medical Inc for the previous quarter, Wall Street now forecasts 11.76 % EPS growth. The stock decreased 1.40% or $0.5 on September 15, reaching $35.1. About 310,860 shares traded. Natus Medical Inc (NASDAQ:BABY) has risen 4.38% since September 17, 2016 and is uptrending. It has underperformed by 12.32% the S&P500.

Natus Medical Inc (NASDAQ:BABY) Ratings Coverage

Among 4 analysts covering Natus Medical (NASDAQ:BABY), 3 have Buy rating, 0 Sell and 1 Hold. Therefore 75% are positive. Natus Medical had 9 analyst reports since July 23, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Thursday, October 22 by TH Capital. Roth Capital maintained the shares of BABY in report on Tuesday, April 5 with “Buy” rating. The company was maintained on Thursday, July 23 by TH Capital. The rating was initiated by Benchmark with “Buy” on Tuesday, October 4. Roth Capital maintained Natus Medical Inc (NASDAQ:BABY) on Friday, June 23 with “Buy” rating. The rating was upgraded by Raymond James to “Outperform” on Tuesday, September 13. The stock of Natus Medical Inc (NASDAQ:BABY) has “Buy” rating given on Tuesday, January 12 by TH Capital. The rating was maintained by Roth Capital with “Buy” on Monday, September 11. Raymond James downgraded the stock to “Mkt Perform” rating in Thursday, February 2 report.

Natus Medical Incorporated is a provider of newborn care and neurology healthcare services and products used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders. The company has market cap of $1.16 billion. The Company’s product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products, such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, incubators to control the newborn’s environment, and software systems for managing and tracking disorders and diseases for public health laboratories. It has a 61.62 P/E ratio.

More notable recent Natus Medical Inc (NASDAQ:BABY) news were published by: Fool.com which released: “Natus Medical Incorporated in 4 Charts” on December 05, 2016, also Nasdaq.com with their article: “Natus Medical Inc (BABY) President and CEO James B Hawkins Bought $135920 of …” published on June 16, 2017, Nasdaq.com published: “Eos Focused Equity Management, LP Buys Univar Inc, Natus Medical Inc, General …” on August 08, 2017. More interesting news about Natus Medical Inc (NASDAQ:BABY) were released by: Fool.com and their article: “Why Natus Medical Inc. Sank Today” published on April 26, 2017 as well as Fool.com‘s news article titled: “Natus Medical Inc. Fell 11% in April. Here’s Why.” with publication date: May 08, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.